Palisade BioPALI
13F holders, Q1 2025 (March 31)13holders +3
4new positions
1sold out
$0.68avg. 13F price*
At the end of Q1 2025, 13 institutions reported holding Palisade Bio Inc. (PALI) in their 13F filings, up 3 from Q4 2024. 4 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($99K), UBS Group AG ($26K) and Marex Group Ltd ($24K).
- Company
- Palisade Bio Inc.
- CUSIP
- 696389402
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $32K |
| Exits | 1 | $116K |
All 13F filers, Q4 2024 → Q1 2025: 131,498 shares bought and 70,122 shares sold, net +61,376 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Armistice Capital, LLC | 0.00% | Add +37.4% | 144,764 | $99K |
| UBS Group AG | 0.00% | Add +324.4% | 38,083 | $26K |
| Marex Group Ltd | 0.00% | No change | 35,759 | $24K |
| Geode Capital Management, LLC | 0.00% | Add +146.0% | 24,732 | $17K |
| HRT Financial LP | 0.00% | New | 18,264 | $12K |
| Virtu Financial LLC | 0.00% | New | 15,255 | $10K |
| Two Sigma Securities, LLC | 0.00% | New | 14,153 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -2.5% | 4,570 | $3K |
| Morgan Stanley | 0.00% | Add +8871.4% | 628 | $428 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 100 | $68 |
| Bank of America Corp. | 0.00% | Add +130.0% | 23 | $16 |
| Wells Fargo & Company | 0.00% | No change | 21 | $14 |
| Barclays PLC | 0.00% | New | 6 | $4 |
"% of holder's portfolio" is PALI's weight in each manager's 13F, not the share of Palisade Bio Inc. the manager owns.